Skip Navigation


Hum. Reprod. Advance Access originally published online on April 14, 2008
Human Reproduction 2008 23(6):1472-1473; doi:10.1093/humrep/den117
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow All Versions of this Article:
23/6/1472-a    most recent
den117v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ankum, W. M.
Right arrow Articles by Offringa, M.
PubMed
Right arrow Articles by Ankum, W. M.
Right arrow Articles by Offringa, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTERS TO THE EDITOR

Reply: Ethical recruitment of patients for PGS trial

Willem M. Ankum1,4, Johannes B. Reitsma2 and Martin Offringa3

1 Department of Obstetrics and Gynaecology, Academic Medical Centre, University of Amsterdam, The Netherlands 2 Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, University of Amsterdam, The Netherlands 3 Department of Paediatric Clinical Epidemiology, Academic Medical Centre, University of Amsterdam, The Netherlands

4 Correspondence address. E-mail: w.m.ankum@amc.uva.nl

The first 10% of the full text of this article appears below.

Sir,

In their response to our paper, Zosmer, Epstein and Al-Shawaf have expressed ethical reservations regarding both our decision to set symmetrical criteria for early termination of the preimplantation genetic screening (PGS) trial, as well as the appropriateness of our justification for doing so (Mastenbroek et al., 2007Go; Ankum et al., 2008Go).

Whenever promising new treatments have already . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?